GB906014A - Pharmaceutical preparations - Google Patents
Pharmaceutical preparationsInfo
- Publication number
- GB906014A GB906014A GB21374/59A GB2137459A GB906014A GB 906014 A GB906014 A GB 906014A GB 21374/59 A GB21374/59 A GB 21374/59A GB 2137459 A GB2137459 A GB 2137459A GB 906014 A GB906014 A GB 906014A
- Authority
- GB
- United Kingdom
- Prior art keywords
- salt
- divinyl benzene
- resin
- carbinoxamine
- dimethylaminoethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A resin drug salt having prolonged anti-histamine effect is obtained by mixing a finely-divided cation exchange resin obtained by sulphonation of a copolymer of styrene and divinyl benzene in which the polymer is crosslinked with from 5 to 15% of divinyl benzene and there being between one and two sulphonic acid groups per benzene ring, with a water solution of a salt of carbinoxamine [2{p-chloro-a - (2 - dimethylaminoethoxy) - benzyl}pyridine]. Pharmaceutical compositions containing the resin drug salt are exemplified.ALSO:Pharmaceutical compositions in tablet, troche, lozenge, capsule, suspension or ointment form comprise a resin drug salt having prolonged anti-histamine effect and obtained by mixing a cation exchange resin which is a sulphonated copolymer of styrene and divinyl benzene with water solution of a salt of carbinoxamine [2{p-chloro - a - (2 - dimethylaminoethoxy) - benzyl} pyridine]. The compositions may comprise ingredients selected from gelatine, water, glycols, suspending agents, oils, alcohols, starches, sugars, kaolin, salts, lubricants, binders, aluminium hydroxide, pigments, vanillin, calcium stearate, tragacanth, sodium benzoate, methyl and propyl para-hydroxybenzoate, and citric acid.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74398858A | 1958-06-23 | 1958-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB906014A true GB906014A (en) | 1962-09-19 |
Family
ID=24990996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB21374/59A Expired GB906014A (en) | 1958-06-23 | 1959-06-22 | Pharmaceutical preparations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB906014A (en) |
-
1959
- 1959-06-22 GB GB21374/59A patent/GB906014A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL187488C (en) | Fluorinated copolymer as well as a cation-exchanging membrane manufactured under its use and vinyl ether suitable for the preparation of the copolymer. | |
FR2441625A1 (en) | (D2-IMIDAZOLINYL-2 AMINO) -5 PYRIMIDINES, PROCESS FOR PREPARING THEM, AND MEDICINAL PRODUCTS CONTAINING SAME | |
ES8105746A1 (en) | (N-phosphonoacetyl-L-aspartato) (1,2 diaminocyclohexane) platinum (II) and the sodium, potassium or lithium salts thereof, their preparation and pharmaceutical compositions containing them. | |
PT72131A (en) | Novel fluorinated copolymer and preparation thereof | |
GB1490237A (en) | Detergent tablet for personal washing | |
CA987595A (en) | Cosmetic composition comprising an aqueous solution of sodium polystyrene sulfonate | |
BE857002A (en) | PROCESS FOR PREPARING AN AQUEOUS COMPOSITION INTENDED TO RENDER WOOL IRRERECHISSABLE | |
GB865836A (en) | Chemical process and products | |
GB906014A (en) | Pharmaceutical preparations | |
GB1383939A (en) | Battery electrolyte composition | |
ES414862A1 (en) | Food compositions | |
GB982150A (en) | Therapeutic resin complexes | |
GB1363834A (en) | Sodium aluminium borate and preparation thereof | |
GB1427831A (en) | Cross-linked filamentary ion-exchange resins | |
GB1212943A (en) | 0,1,1,3,3-pentafluoro-2-propyl p-toluenesulphonate | |
GB1294299A (en) | Isoniazid derivative | |
GB960049A (en) | Improvements in or relating to cation exchange resins | |
BE812378A (en) | PERFECTED PROCESS FOR PREVENTING THE FORMATION OF UNWANTED SECONDARY COMPOUNDS IN THE SULPHONATION OR SULFATION OF ORGANIC COMPOUNDS | |
GB1126694A (en) | Optically active new salt complexes and their applications | |
GB1303963A (en) | ||
GB1409948A (en) | Oligoethylenepiperazines | |
BE815800A (en) | PROCESS FOR PREPARING A SULFONE OR A MIXTURE OF SULPHONES | |
KR910011875A (en) | Sulfonated propylphenylphosphine, preparation method and use thereof | |
GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
GB970965A (en) | Ajmaline derivatives |